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applications. Microspheres can be produced for protection 
of core material, reduction of gastric irritation decrease 
in volatility, conversion of liquid to pseudo-solid, cell 
microencapsulation, and designing pulsatile drug delivery 
systems. Administration of the drug in the form of 
microspheres usually improves the treatment by providing 
the localization of the active substances at the site of action 
and by prolonging release of drugs.[1]
Naproxen is a newer nonsteroidal anti-inflammatory drug 
(NSAID), most useful drug for showing effective anti-
inflammatory and analgesic properties and mainly used 
in osteoarthritis, rheumatoid arthritis, and ankylosing 
spondylitis.[2,3] Naproxen is rapidly and efficiently absorbed 
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ABSTRACT
The objective of this study was to microencapsulate the anti-inflammatory drug (naproxen) to provide controlled 
release and minimizing or eliminating local side effect by avoiding the drug release in the upper gastrointestinal 
track. Naproxen was microencapsulated with lipid-like carnauba wax, hydrogenated castor oil using modified 
melt dispersion (modified congealable disperse phase encapsulation) technique. Effect of various formulation 
and process variables such as drug-lipid ratio, concentration of modifier, concentration of dispersant, stirring 
speed, stirring time, temperature of external phase, on evaluatory parameters such as size, entrapment efficiency, 
and in vitro release of naproxen were studied. The microspheres were characterized for particle size, scanning 
electron microscopy (SEM), FT-IR spectroscopy, drug entrapment efficiency, in vitro release studies, for in vitro 
release kinetics. The shape of microspheres was found to be spherical by SEM. The drug entrapment efficiency 
of various batches of microspheres was found to be ranging from 60 to 90 %w/w. In vitro drug release studies 
were carried out up to 24 h in pH 7.4 phosphate buffer showing 50-65% drug release. In vitro drug release from 
all the batches showed better fitting with the Korsmeyer-Peppas model, indicating the possible mechanism of 
drug release to be by diffusion and erosion of the lipid matrix.
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after oral administration but has a short half-life of 1-3 h 
and requires multiple dosing for maintaining therapeutic 
effect throughout the day.[4] The most frequent adverse side 
effects occurring with naproxen are gastrointestinal (GI) 
disturbances, peptic ulceration, and GI bleeding. To reduce 
the frequency of administrations and to improve patient 
compliance, naproxen is a suitable for making sustained 
release dosage form.[5,6]
Despite the advent of natural and synthetic polymers in 
microsphere preparation, there are number of advantages 
of lipid materials as matrixing agents like they are 
biocompatible, biodegradable, nonimmunogenic, can 
entrap wide range of water insoluble compounds and are 
economic as per as formulation of novel dosage form 
is concerned.[7] Preparation of controlled release lipid 
microspheres is commonly achieved using melt dispersion 
(congealable disperse phase encapsulation) technique, 
which utilizes fats of animals and/or vegetable origin as 
the matrix. This technique is especially suitable for drugs, 
which are insoluble in water. Taking into account the above 
considerations, lipid microspheres of naproxen using 
carnauba wax as a lipid carrier were prepared by modified 
melt dispersion technique.
MATERIALS AND METHODS
Materials
Naproxen was a gift sample from RPG Life Sciences Ltd. 
(Ankleshwar, India). Hydrogenated castor oil (HCO) was 
obtained from National Chemicals, Vadodara. Carnauba 
wax and glycerol monosterate were provided by Rankem 
(RFCL Limited), New Delhi, India. All other chemicals 
used were of analytical grade.
Methods
Preparation of  lipid microspheres
Naproxen microspheres were prepared by modified 
melt dispersion technique.[8] Carnauba wax and HCO 
(lipid) with or without modifier were melt on the heating 
mantle. Naproxen (drug) was dispersed in the molten lipid. 
Temperature of this fatty phase was maintained at about   
10 °C above the melting point of lipid (i.e., at 90 °C). Then, 
0.1 N HCl containing poly vinyl alcohol (PVA) 0.5%w/v 
as a dispersant was maintained at about 5°C above the 
melting point of lipid (85 °C). The fatty phase was poured 
into this solution while continuous stirring at an 800 rpm 
to form an o/w emulsion. The resultant emulsion was 
then agitated for 3 min while maintaining the temperature. 
Hardening of the oily internal phase and formation of 
microspheres were accomplished by pouring, twice the 
emulsion volume of ice-cold acidified water (4°C) into 
the beaker and stirring continuously for further 15 min 
in an ice bath. Microspheres obtained were filtered under 
vacuum and washed five times with phosphate buffer (pH 
7.4) to remove the unentrapped drug and dried in room 
temperature for 24 h.
Effect of formulation and process variables on 
evaluatory parameters[8]
The release of drug from microspheres is influenced 
by number of factors such as nature of carrier, drug 
concentration, dispersant concentration, stirring speed, 
stirring time, external-phase temperature, and external 
phase. Taking into account the above considerations, 
effects of various formulation and process variables on 
size, entrapment efficiency, and in vitro release of naproxen 
were studied. The different batches of microspheres were 
prepared by changing each of the parameters (one at a 
time) and keeping others constant.
Effect of  drug-lipid ratio
The effect of drug-lipid ratio was studied on the 
preparation of naproxen-loaded microspheres using 
carnauba wax[9] and HCO as a carrier. Different batches 
with drug-lipid ratio of 1:3, 1:4, and 1:5 were prepared 
by modified melt dispersion technique as shown in   
Table 1. The other variables were kept constant. The effect 
of variables on microspheres prepared was then evaluated 
for different evaluatory parameters such as size, entrapment 
efficiency, and in vitro release.
Effect of  concentration of  modifier
The effect of glycerol monosterate as a lipid modifier with 
different concentrations was studied in combination with 
carnauba wax by the same technique. Different batches 
with 25% w/w, 37.5% w/w, and 50% w/w of glycerol 
monostearate in combination with carnauba wax were 
prepared as shown in Table 2.
Table 1: Effect of drug-lipid ratio on evaluatory 
parameters
Batches with 
carnauba wax
A1 A2 A3
Batches with 
hydrogenated castor 
oil
A4 A5 A6
Drug:lipid 1:3 1:4 1:5
Modifier No No No
Dispersant PVA (0.5% w/v) PVA (0.5% w/v) PVA (0.5% w/v)
Stirring speed 800 rpm 800 rpm 800 rpm
Stirring time 3 min 3 min 3 min
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Effect of  concentration of  dispersant
The effect of various concentrations of PVA (dispersant) 
was studied by preparing different batches with 0.25% w/v, 
0.5% w/v, and 0.75% w/v of PVA with respect to volume 
of dispersion media. All other variables were kept constant.
Effect of  stirring speed
The effect of stirring speed on the preparation of 
microspheres was studied by preparing various batches with 
500, 800, and 1100 rpm, using a variable speed mechanical 
stirrer and keeping all other variables constant.
Effect of  stirring time
The effect of emulsification time was studied on the 
preparation of microspheres. The batches with varying 
emulsification-stirring time of 1, 3, and 5 min were 
prepared and evaluated, keeping all other variables constant.
Effect of  temperature of  external phase
The effect of temperature of external phase (0.1 N HCl) on 
the preparation of microspheres were studied at different 
temperature like ≤85°, 85, and ≥85 °C keeping all other 
variables constant. For all the batches, carnauba wax was 
used as a lipid material and 0.1 N HCl containing optimum 
concentration of PVA was used as a dispersion medium. 
The effect of variables on microspheres prepared was then 
evaluated for different evaluatory parameters such as size, 
entrapment efficiency, and in vitro release.
Effect of  external phase
The effect of different external phase on the preparation 
of microspheres such as water, 0.1 N HCl, and pH 7.4 
phosphate buffer was studied keeping all other variables 
constant.
Evaluatory parameters
Size
Size distribution analysis of microspheres was done by 
optical microscopy using motic microscope. The diameters 
were sized using a suitable objective (10× and 40×). An 
average of 50 particles was calculated for each variable 
studied.[10]
Entrapment efficiency[9]
Entrapment efficiency in microspheres is very important to 
study the efficiency of the process. Entrapment efficiency 
of all the batches prepared to study the effect of various 
variables was determined spectrophotometrically using UV 
2300, Techcomp. An approximate weight of about 100 mg 
of microspheres containing drug was added to phosphate 
buffer (pH 7.4) solution. The mixture was heated in order 
to melt lipid microspheres and to extract the drug into 
the solution. Then, this solution was allowed to cool up 
to room temperature to precipitate out the lipids and then 
filtered. After diluting with sufficient quantity of phosphate 
buffer (pH 7.4), drug concentration was determined by 
UV spectrophotometry at 317 nm using pH 7.4 phosphate 
buffer as a blank. Entrapment efficiency was calculated by 
using following formula: 
  Drug entrapped
Entrapment efficiency =   × 100.
  Theoretical drug content
In vitro release studies[9]
United State Pharmacopoeia (USP) rotating  basket method 
II (paddle type) has been employed for dissolution testing 
of microspheres at 50 rpm with temperature of 37 ± 
0.5°C (Electrolab TDT-06P). Microspheres that showed 
acceptable physical properties were selected for the in 
vitro release studies. The procedure and composition of 
dissolution media were as per USP method described for 
naproxen tablets. Five-hundred milligrams of naproxen 
microspheres were placed into the dissolution apparatus. 
Five milliliters of dissolution medium was withdrawn by 
a pipette after a regular interval of 1, 2, 3, 4, 5, 6, 7, 8, 9, 
10, 11, 12, and 24 h. The volume withdrawn was replaced 
with fresh quantities of dissolution fluid (phosphate buffer 
pH 7.4) maintained at 37 ± 0.5°C. Samples withdrawn 
were diluted to 10 mL with pH 7.4 phosphate buffer and 
filtered. The filtered samples were then analyzed at 317 
nm against blank using double beam spectrophotometer, 
and absorbance was noted. The amount of drug released 
was calculated using the standard calibration curve for 
naproxen.
Characterization of microspheres
Surface topography by SEM
SEM photographs were taken using scanning electron 
microscope model JOEL-LV-5600, USA at suitable 
magnification at room temperature. The shape and 
surface morphology of carnauba wax loaded naproxen 
microspheres were investigated using SEM. The samples 
for SEM study were prepared by lightly sprinkling the 
formulation on a double-adhesive tape stuck to an 
Table 2: Effect of modifier concentration on evaluatory 
parameters
Batch B1 (25%w/w) B2 (37.5%w/w) B3 (50%w/w)
Mean diameter 
(µm) ± SD
182 ± 33 235 ± 45 292 ± 34
Entrapment 
efficiency (%)
53.73% 49.60% 37.44%
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aluminum stub. The stubs were then coated with gold 
to a thickness of ~300 Å under an argon atmosphere 
using a gold sputter module in a high-vacuum evaporator. 
The coated samples were then randomly scanned and 
photomicrographs were taken.[11]
FT-IR spectroscopy
The FT-IR spectra were taken from dried samples. A 
FT-IR was used for the analysis in the frequency range 
between 4000 and 600 cm-1, an 8 cm-1 resolution and 
a 0.2 cm-1 rate (8400 S, Shimadzu Asia Pacific Pt. Ltd, 
Singapore). The samples (2 mg of the pure drug naproxen, 
empty microspheres, and naproxen-loaded carnauba wax 
microspheres) were selected separately and dispersed in 
KBr powder: the pellets were made by applying 6000 kg/
cm2 and analyzed. Spectral measurements were obtained by 
powder diffuse reflectance on a FT-IR spectrophotometer.
Drug release kinetics
To study the exact mechanism of drug release from the 
microsphere, drug release data were analyzed according 
to zero-order, first-order, Higuchi square root, Hixson 
Crowell, and Peppas equation. The criteria for selecting 
the most appropriate model were chosen on the basis of 
goodness of fit test.[11]
RESULTS AND DISCUSSION
Effect of drug-lipid ratio revealed that entrapment 
efficiency value was high in case of carnauba wax and HCO, 
i.e., more than 80% up to drug-lipid ratio of 1:4, while it 
is drastically decreased in both the lipids, if the lipid ratio 
was increased to 1:5. This decrease in entrapment efficiency 
might be due to maximum solubility of the drug in the lipid 
melt and any further increase in lipid amount might lead 
to its expulsion out of the melt. The optimum drug-lipid 
ratio for the preparation of carnauba wax microspheres 
with high-entrapment efficiency (83.59%) and particle size 
(159 ± 33 µm) was found at the ratio of 1:3, while in case 
of HCO, the optimum drug-lipid ratio was also 1:3 with 
89.87% entrapment efficiency and 169 ± 34 µm particle 
size. As lipid amount was increased, the mean diameter of 
microspheres in both the cases was increased. This might 
be due to increase in viscosity of lipid melted with drug, 
which consequently increased the diameter of emulsion 
droplets during emulsification and ultimately the mean 
diameter of microspheres. Effect of drug-lipid ratio on 
in vitro release profile of naproxen with carnauba wax as 
a carrier is shown in Figure 1. It was observed that the 
drug-lipid ratio 1:3 showed greater release, i.e., up to 70% 
in 24 h as compared to other because of finer particle size, 
thus increasing the surface area for dissolution. Also, in 
case of HCO as shown in Figure 2, it was observed that 
the drug-lipid ratio 1:3 shows greater release but less than 
that of carnauba wax (60% up to 24 h).
From the above-mentioned study, it could be revealed that 
the release rate of naproxen was greater from the lipid 
carnauba wax as compared to HCO. This might be due to 
low-melting point of carnauba wax than the HCO. Because 
the higher the melting point of lipid/wax, the slower was 
the cumulative amount of drug release. Thus, melting 
point of lipid/wax is inversely proportional to drug release. 
Therefore, carnauba wax was used in further studies.
Effect of concentration of modifier shows low-entrapment 
efficiency with optimum particle size. However, as the 
concentration of modifier was increased, mean diameter 
was found to be increased, with a maximum of 292 ± 34 
[(µm) ± SD] with 50% w/w concentration of glycerol 
Figure 1: Effect of drug-lipid (carnauba wax) ratio on in vitro dissolution 
profile of naproxen in pH 7.4 phosphate buffer
Figure 2: Effect of drug-lipid (hydrogenated castor oil) ratio on in vitro 
dissolution profile of naproxen
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monosterate. This might be due to increase in viscosity by 
the addition of modifier. Effect of modifier concentration 
on in vitro release profile of naproxen is shown in Figure 3. 
In vitro release studies showed that the release rate of the 
naproxen was increased by the addition of the modifier 
as compared to drug-lipid ratio. The reasons for greater 
release might be decrease in the melting temperature of 
lipid by the addition of the modifier. As the concentration 
of modifier was increased, drug release was found to be 
slower and lesser was the cumulative amount of drug 
released.
Effect of concentration of dispersant shows that, as the 
concentration of dispersant was increased, entrapment 
efficiency was increased. Use of polyvinyl alcohol (0.75% 
w/v) resulted in discrete, spherical uniform microspheres 
with 83.68% entrapment efficiency and 167 ± 39 particle 
size. Thus, polyvinyl alcohol in the concentration of 0.75% 
w/v was found to be optimum dispersant for microsphere 
preparation. As the concentration of dispersant was 
increased, mean diameter of microspheres was decreased. 
At low-dispersant concentrations, the droplets were poorly 
stabilized and tend to coalesce and became larger particle. 
Another reason for decrease in mean diameter might be 
decrease in interfacial tension between the hydrophobic 
material and aqueous external phase leading to formation 
of initially smaller droplets yielding smaller microspheres. 
Effect of dispersant concentration on in vitro release profile 
of naproxen is shown in Figure 4. From the results, it was 
revealed that batch C3 shows greater release profile of 
naproxen as compared to other two batches. Thus, the 
0.75% w/v concentration of polyvinyl alcohol shows 
the greater release as compared to other because of finer 
particle size.
Optimum stirring speed, which yielded microspheres with 
highest entrapment efficiency of 85.33% and particle size 
of 125 ± 58 µm was found to be 1100 rpm. Higher stirring 
speed (i.e., 1100 rpm) resulted in decrease in emulsion 
droplet size and higher proportion of smaller microspheres 
was formed as can be seen from mean diameter. On 
the other hand, stirring speed below 800 (i.e., 500 rpm) 
resulted in the formation of microspheres with larger 
mean diameter. Effect of stirring speed on in vitro release 
profile of naproxen is shown in Figure 5. It was observed 
that the batch D3 showed greater release of naproxen 
than that of D1 (500 rpm) and D2 (800 rpm). The reason 
for greater drug release from the batch D3 might be finer 
particle size, thus larger surface area of microspheres than 
that of microspheres prepared at 500 rpm (Batch D1) and 
800 rpm (Batch D2).
Effect of stirring time revealed that emulsification-
Figure 5: Effect of stirring speed on in vitro dissolution profile of 
Naproxen
Figure 3: Effect of modifier (glycerol monosterate) concentration on 
in vitro dissolution profile of Naproxen
Figure 4: Effect of dispersant concentration on in vitro dissolution 
profile of naproxen
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Figure 7: SEM photographs of microspheres (Batch A2) at ×100, ×110, 
×190, ×500, ×1000, ×1500 and ×2000 magnification
Figure 6: Effect of stirring time (emulsification) on in vitro dissolution 
profile of naproxen
Figure 8: FT-IR Spectra of a) Naproxen b) Naproxen loaded 
microspheres c) Empty microspheres of carnauba wax d) Overlapping 
of and B
a
c d
b
stirring time has also significant effect on entrapment 
efficiency and particle size of microspheres. However 
at an emulsification stirring time of 1 min (batch E1), 
agglomerates or aggregates were formed with large 
variation in mean diameter. Discrete, free flowing, uniform, 
and finer microspheres were formed at emulsification 
stirring time of 3 min (batch E2) and 5 min (batch E3). 
However, mean diameter of batch E2 was found to be 
greater than that of batch E3 (5 min). The reason for 
this increase in mean diameter followed by increasing 
emulsification time might be as follows; it has been reported 
that increase in homogenization time increases the energy 
input which might lead to decrease in the mean diameter of 
microspheres up to a minimum after which it might increase 
due to over emulsification. Effect of emulsification stirring 
time on in vitro release of naproxen is shown in Figure 6.
In vitro release profile of batches E1, E2, and E3   
[Figure 6] showed that the drug release from batch E1 was 
slower than the other two batches. Again the reason for this 
slower drug release might be larger mean diameter of batch 
E1, leading to lesser surface area available for dissolution.
Effect of temperature of external phase revealed that the 
optimum temperature of external phase should be 85°C 
for the preparation of microspheres, i.e., 5°C greater than 
the melting point of wax (carnauba wax 80°C) and if it is 
greater or less than this temperature, it did not lead to the 
formation of microspheres.
Effect of external phase revealed that the microspheres 
were formed if the 0.1 N HCl was taken as the external 
phase. This might be due to the fact that the drug naproxen 
is soluble in pH 7.4 phosphate buffer which did not result 
in the formation of emulsion droplets while it is insoluble 
in water which also lead to the same condition and it is 
sparingly soluble in 0.1 N HCl which lead to the formation 
of emulsion droplets which after stirring formed the 
microspheres.
Figure 7 shows SEM photographs of microspheres (Batch 
A2) at 100× magnification, 110×, 190×, 500×, 1000×, 
1500×, and 2000× magnification. SEM photographs 
showed discrete, spherical, and uniform microspheres. 
SEM photographs also showed the absence of any drug 
crystal on the surface of microspheres revealing that the 
microspheres were smooth.
The FT-IR spectra of pure drug (naproxen), naproxen-
loaded (carnauba) wax microspheres, empty microspheres, 
and overlapping of naproxen and naproxen-loaded 
microspheres are shown in Figure 8. From the FT-IR 
studies, it was observed that the peaks of naproxen were 
Bhoyar, et al.: Encapsulation of laproxen in lipid-based matrix microspheresJournal of Young Pharmacists Vol 3 / No 2  111
Table 3: Correlation coefficient values for release 
kinetics of lipid microspheres
Batch 
no.
Zero-order First-order Matrix 
(Higuchi)
Korsmeyer-
Peppas
Hixson-
Crowell
A1 0.5236 0.7938 0.9674 0.9746 0.7259
A2 0.9140 0.9332 0.9252 0.9610 0.9508
A3 0.9374 0.9247 0.9066 0.9610 0.9579
B1 0.2223 0.7939 0.9585 0.9698 0.6885
B2 0.2311 0.8148 0.9673 0.9786 0.7043
B3 0.9259 0.9270 0.9289 0.9679 0.9631
C1 0.9217 0.9428 0.9228 0.9545 0.9467
C3 0.8317 0.9397 0.9622 0.9632 0.9145
detected and identified in the spectrum of naproxen-loaded 
microspheres confirming that there was no drug-lipid 
interaction between naproxen and carnauba wax.
The mechanism of naproxen release from microspheres 
was studied by fitting the data obtained from in vitro release 
studies into zero-order, first order, matrix, Hixson-Crowell’s, 
and Peppas kinetic models. Obtained values of correlation 
coefficient are given in Table 3. It was found that all the 
batches showed better fitting with the Korsmeyer-Peppas 
model. The Korsmeyer-Peppas equation gave consistently 
higher values for the correlation coefficient (above 0.9545) 
than the other release models. Thus, the drug release from 
all the microsphere preparations confirmed Korsmeyer-
Peppas model indicating the release mechanism may be by 
diffusion and erosion of the lipid matrix. This may be due 
to the fact that microspheres are matrix-type and swelling 
or erosion of microspheres took place during drug release 
experiments.
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